| Dr Noel L Elgut, MD | |
|
6333 N Federal Hwy, Ft Lauderdale, FL 33308-1907 | |
| (954) 463-4761 | |
| (954) 463-4763 |
| Full Name | Dr Noel L Elgut |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 38 Years |
| Location | 6333 N Federal Hwy, Ft Lauderdale, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548243843 | NPI | - | NPPES |
| 063637100 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | ME58120 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Broward Health Imperial Point | Fort lauderdale, FL | Hospital |
| Entity Name | Magruder Eye Institute Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881661692 PECOS PAC ID: 3971582024 Enrollment ID: O20040714000562 |
News Archive
A study provides new insight into how the stiffening of breast tissue plays a role in breast cancer development. By examining how mammary cells respond in a stiffness-changing hydrogel, bioengineers at the University of California San Diego discovered that several pathways work together to promote the transformation of breast cells into cancer cells.
A team of scientists led by Dr. Kuniya Abe from the RIKEN BioResource Center in Japan has performed one of the most comprehensive genome-wide experimental analyses of sense-antisense transcripts to date. Their findings are published in the April issue of the journal Genome Research.
ARUP Laboratories, a leading national clinical and anatomic pathology reference laboratory and a leader in innovative laboratory research and development, today announced it is offering the Septin 9 methylated DNA test, a new blood-based colorectal cancer screening method. While ARUP is not the first laboratory to offer this test, this new version, developed and validated independently by ARUP, is clinically proven to detect a higher proportion of colorectal cancers than Septin 9 tests developed by other companies.
Mount Sinai School of Medicine researchers will present several landmark studies, including data on treatment trends in late-stage cancer, a promising multiple myeloma vaccine, and predictive models of soft tissue sarcomas, prostate and bladder cancer, at the 2012 American Society of Clinical Oncology (ASCO) meeting June 1-5, 2012 in Chicago.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Noel L Elgut, MD 6333 N Federal Hwy, Suite 401, Ft Lauderdale, FL 33308-1907 Ph: (954) 463-4761 | Dr Noel L Elgut, MD 6333 N Federal Hwy, Ft Lauderdale, FL 33308-1907 Ph: (954) 463-4761 |
News Archive
A study provides new insight into how the stiffening of breast tissue plays a role in breast cancer development. By examining how mammary cells respond in a stiffness-changing hydrogel, bioengineers at the University of California San Diego discovered that several pathways work together to promote the transformation of breast cells into cancer cells.
A team of scientists led by Dr. Kuniya Abe from the RIKEN BioResource Center in Japan has performed one of the most comprehensive genome-wide experimental analyses of sense-antisense transcripts to date. Their findings are published in the April issue of the journal Genome Research.
ARUP Laboratories, a leading national clinical and anatomic pathology reference laboratory and a leader in innovative laboratory research and development, today announced it is offering the Septin 9 methylated DNA test, a new blood-based colorectal cancer screening method. While ARUP is not the first laboratory to offer this test, this new version, developed and validated independently by ARUP, is clinically proven to detect a higher proportion of colorectal cancers than Septin 9 tests developed by other companies.
Mount Sinai School of Medicine researchers will present several landmark studies, including data on treatment trends in late-stage cancer, a promising multiple myeloma vaccine, and predictive models of soft tissue sarcomas, prostate and bladder cancer, at the 2012 American Society of Clinical Oncology (ASCO) meeting June 1-5, 2012 in Chicago.
› Verified 4 days ago
Dr. Eric Charles Gechter, MD Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 2900 W Cypress Creek Rd, Suite 1, Ft Lauderdale, FL 33309 Phone: 954-977-0192 Fax: 954-977-0197 | |
Daniel Gologorsky, MD, MBA Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 1625 Se 3rd Ave Ste 501, Ft Lauderdale, FL 33316 Phone: 954-468-8072 Fax: 954-468-8087 | |
Patrick E Rubsamen, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6333 N Federal Hwy, Suite 300, Ft Lauderdale, FL 33308 Phone: 954-776-6880 Fax: 954-229-3100 | |
Dr. Krista D Rosenberg, Ophthalmology Medicare: Medicare Enrolled Practice Location: 6333 N Federal Hwy, Suite 300, Ft Lauderdale, FL 33308 Phone: 954-776-6880 Fax: 954-229-3100 | |
George A Fournier, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2466 E Commercial Blvd, Ft Lauderdale, FL 33308 Phone: 954-492-1177 Fax: 954-492-0352 | |
Dr. Robert Lee Kramm Iii, MD, MSE Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1281 S Ocean Dr, Ft Lauderdale, FL 33316 Phone: 720-252-8488 | |
John F Sciarrino, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5601 N. Dixie Hwy, Ste 115, Ft Lauderdale, FL 33334 Phone: 954-771-4271 Fax: 954-776-5959 |